FM

Frank Mccormick

Advisory Board Member at Portola Pharmaceuticals

Frank McCormick, Ph.D., is an internationally renowned molecular biologist and cancer researcher who helped pave the way toward the development of targeted cancer therapies. Dr. McCormick is director of the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center and has led the UCSF Cancer Center program since its inception in 1998. He holds the E. Dixon Heise Distinguished Professorship in Oncology and the David A. Wood Distinguished Professorship of Tumor Biology and Cancer Research at UCSF. He is also the associate dean of the UCSF School of Medicine and a distinguished Professor in Residence in the Department of Microbiology and Immunology as well as in the Department of Biochemistry and Biophysics. He is president-elect of the American Association for Cancer Research, an elected member of the Institute of Medicine of the National Academy of Sciences, and a Fellow of the Royal Society.

Timeline

  • Advisory Board Member

    Current role